Additionally, we observed a higher prevalence of TP53 somatic mutations within this cluster, suggesting that reduced functionality of this well-known tumour suppressor gene may contribute to immune activation in Asian HR + /HER2− breast cancer. This evidence concerns the gene TP53 and breast carcinoma.